You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 15, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
1Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD 20892, USA.
Peptide heterodimers, linking two different ligands, significantly enhance tumor targeting affinity and retention time for molecular imaging probes compared to single peptides. This approach shows promise for multi-receptor overexpressed tumors.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: